- Clinical trials of the anti-parasitic drug niclosamide for COVID-19 will be conducted in August 2020 by Mankind Pharma of Delhi and Daewoong Pharmaceutical of South Korea.
- To address the severe lack of injectables in hospitals and clinics, Piramal Critical Care (PCC) and Medivant Healthcare, a US-based pharmaceutical outsourcing facility, engaged into a strategic alliance in July 2020.
